Russia: Analysing the case of Lunos v Linos

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Russia: Analysing the case of Lunos v Linos

Despite the seemingly unlimited choice of words and the vast imagination of people, collision between similar words, real or coined, is not infrequent. In normal life these words are homonyms or homophones and do not pose any problems in everyday activities. It is a different story in the world of intellectual property. Same or similar words may mean different things but in the eyes of the consumer they are the same and for businesses they may mean loss.

Long ago, there was an international registration No 754940 covering in Russia and other countries the trade mark LINOS with priority of the year 2000 for goods in Class 10. Later, another international trade mark No 1279699 LUNOS was extended to Russia for the goods in Classes 3, 5, 21 and 10. The patent office recognised registration in all classes except 10. The reason for rejection was the confusing similarity of the trade marks.

The applicant of LUNOS appealed the decision of the patent office. He also submitted an irrevocable letter of consent for the goods in Class 10 from the cited trade mark owner (LINOS). The Chamber of Patent Disputes pointed out that the letter of consent could not have been taken into account by the examiner at the time of examination and accepted the appeal.

The law allows coexistence of a confusingly similar trade mark with the cited trade mark if the owner of that mark agrees to coexistence and if consumers are not misled about the relevant goods.

When a decision is taken in the context of a consent letter the patent office nevertheless checks whether confusion is possible and to what degree. It is clear that chances of confusion between goods are growing. The patent office worked out some guidelines for itself to check the possibility of confusion. In particular, it checks (1) whether the claimed designation and the cited trade mark are similar to the extent of sameness; (2) whether the cited trade mark is widely known and whether consumers associate it with a particular manufacturer; and (3) whether the cited trade mark is a collective trade mark and not widely known to consumers.

Even though the practice of submitting letters of consent is routine, this does not mean that all requests of this kind are accepted. The patent office may decline acceptance of the letter of consent if, for example, the trade marks are identical and the goods are the same. These cases are rare though. According to a rough estimate about 90% of letters of consent are accepted and similar trade marks are registered to the satisfaction of applicants.

vladimir

Vladimir Biriulin

Gorodissky & Partners

Russia 129010, Moscow

B. Spasskaya Str

25, stroenie 3

Tel: +7 495 937 6116 / 6109

Fax: +7 495 937 6104 / 6123

pat@gorodissky.ru 

www.gorodissky.com 

more from across site and SHARED ros bottom lb

More from across our site

VO, which has offices in the Netherlands, Belgium and Germany, is the second European IP firm to secure external backing this week
The Bardehle Pagenberg attorneys-at-law discuss the firm’s Managing IP EMEA Awards 2026 success, Unified Patent Court litigation strategy, and evolving European patent trends
A patent battle between two legal tech companies and a loss for Elon Musk’s xAI against OpenAI were also among the top talking points
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market
Academic Eden Sarid joins us during Pride Month to discuss queer expression and IP law, Patagonia v Pattie Gonia, and how queer and AI-generated creations both pose novelty concerns
Patent attorney Michael Henson joins the firm to lead its freshly launched blockchain and digital assets practice
A dispute over mammogram technology, and a development in the case between GSK and Moderna were also among the top talking points in recent weeks
With rankings for Western Europe set to be published on June 25, we sat down with our research lead to find out what practitioners and law firms can expect
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Matteo Di Lernia, advocate at LCA Studio Legale, unpicks the CJEU’s ruling in M.M. Ristorazione v Villa Ramazzini, including its impact on litigation strategies
Gift this article